These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32224063)

  • 21. Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the international society of paediatric oncology (SIOP) nephroblastoma trial and study 9.
    Boccon-Gibod L; Rey A; Sandstedt B; Delemarre J; Harms D; Vujanic G; De Kraker J; Weirich A; Tournade MF
    Med Pediatr Oncol; 2000 Mar; 34(3):183-90. PubMed ID: 10696124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: Results from the SIOP-WT-2001 Registry.
    Dávila Fajardo R; Oldenburger E; Rübe C; López-Yurda M; Pritchard-Jones K; Bergeron C; Graf N; van Grotel M; van Tinteren H; Saunders D; van den Heuvel-Eibrink MM; Janssens GO; Oldenburger F
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27085. PubMed ID: 29693799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of children with clear cell sarcoma of kidney following NWTS strategies in Shanghai China (2003-2021).
    Zhang A; Yuan X; Jiang S; Xu D; Huang C; Tang JY; Gao Y
    PLoS One; 2024; 19(7):e0306863. PubMed ID: 38980838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of Wilms' tumour management in two tertiary-care hospitals in Asia.
    Sen S; Kadamba P; Al-AbdulAaly M; Mammen KE; Ahmed S
    Pediatr Surg Int; 1998 Jan; 13(1):42-4. PubMed ID: 9391203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk stratification and consecutive prognosis progresses in childhood Wilms tumors. Two cases report.
    Diaconescu S; Olaru C; Mihailă D; Aprodu SG; Miron I
    Chirurgia (Bucur); 2013; 108(1):106-11. PubMed ID: 23464780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study.
    Chagtai T; Zill C; Dainese L; Wegert J; Savola S; Popov S; Mifsud W; Vujanić G; Sebire N; Le Bouc Y; Ambros PF; Kager L; O'Sullivan MJ; Blaise A; Bergeron C; Mengelbier LH; Gisselsson D; Kool M; Tytgat GA; van den Heuvel-Eibrink MM; Graf N; van Tinteren H; Coulomb A; Gessler M; Williams RD; Pritchard-Jones K
    J Clin Oncol; 2016 Sep; 34(26):3195-203. PubMed ID: 27432915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges and outcome of Wilms' tumour management in a resource-constrained setting.
    Wilde JC; Lameris W; van Hasselt EH; Molyneux EM; Heij HA; Borgstein EG
    Afr J Paediatr Surg; 2010; 7(3):159-62. PubMed ID: 20859020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localized Wilms' tumor in low-middle-income countries (LMIC): how can we get better?
    Asfour HY; Khalil SA; Zakaria AS; Ashraf ES; Zekri W
    J Egypt Natl Canc Inst; 2020 Aug; 32(1):32. PubMed ID: 32794016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01.
    Graf N; van Tinteren H; Bergeron C; Pein F; van den Heuvel-Eibrink MM; Sandstedt B; Schenk JP; Godzinski J; Oldenburger F; Furtwängler R; de Kraker J
    Eur J Cancer; 2012 Nov; 48(17):3240-8. PubMed ID: 22795263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
    Stefanowicz J; Sierota D; Balcerska A; Stoba C
    Med Wieku Rozwoj; 2004; 8(2 Pt 1):197-200. PubMed ID: 15738594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30-year SIOP-RTSG experience.
    Vujanić GM; Graf N; D'Hooghe E; Pritchard-Jones K; Bergeron C; Tinteren HV; Furtwängler R;
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30852. PubMed ID: 38185745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of patients with Wilms' tumour stage III due to positive resection margins only: An analysis of patients treated on the SIOP-WT-2001 protocol in the UK-CCLG and GPOH studies.
    Vujanić GM; Graf N; D'Hooghe E; Chowdhury T; Vokuhl C; Al-Saadi R; Pritchard-Jones K; Melchior P; Furtwängler R
    Int J Cancer; 2023 Apr; 152(8):1640-1647. PubMed ID: 36444500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa.
    Aronson DC; Hadley GP
    Pediatr Blood Cancer; 2014 Jun; 61(6):987-9. PubMed ID: 24453084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Wilms tumor according to SIOP 9 protocol in Casablanca, Morocco.
    Madani A; Zafad S; Harif M; Yaakoubi M; Zamiati S; Sahraoui S; Benjelloun A; Fehri M; Benchekroun S
    Pediatr Blood Cancer; 2006 Apr; 46(4):472-5. PubMed ID: 16035094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016-2021: Successes and ongoing research priorities.
    Holmes DM; Matatiyo A; Mpasa A; Huibers MHW; Manda G; Tomoka T; Mulenga M; Namazzi R; Mehta P; Zobeck M; Mzikamanda R; Chintagumpala M; Allen C; Nuchtern JG; Borgstein E; Aronson DC; Ozuah N; Nandi B; McAtee CL
    Pediatr Blood Cancer; 2023 May; 70(5):e30242. PubMed ID: 36798020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group.
    Ehrlich PF; Chi YY; Chintagumpala MM; Hoffer FA; Perlman EJ; Kalapurakal JA; Tornwall B; Warwick A; Shamberger RC; Khanna G; Hamilton TE; Gow KW; Paulino AC; Gratias EJ; Mullen EA; Geller JI; Grundy PE; Fernandez CV; Dome JS
    Cancer; 2020 Aug; 126(15):3516-3525. PubMed ID: 32459384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of a Wilms tumour treatment guideline adapted to local circumstances in sub-Saharan Africa: A report from Wilms Africa Phase II-CANCaRe Africa.
    Fufa D; Mdoka C; Ayalew M; Khofi H; Amankwah E; Chokwenda N; Mezgebu E; Mavinkurve-Groothuis AMC; Kamiza S; Chikaphonya-Phiri B; Wassie M; Atwiine B; Branchard M; Gorostegui M; Parkes J; Kudowa E; Eklu B; Jator B; Renner LA; Borgstein E; Molyneux E; Kouya F; Pritchard-Jones K; Paintsil V; Chitsike I; Chagaluka G; Israels T
    Pediatr Blood Cancer; 2024 Nov; 71(11):e31300. PubMed ID: 39198982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wilms' tumor--lessons and outcomes--a 25-year single center UK experience.
    Fawkner-Corbett DW; Howell L; Pizer BL; Dominici C; McDowell HP; Losty PD
    Pediatr Hematol Oncol; 2014 Aug; 31(5):400-8. PubMed ID: 24933082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
    Fernandez CV; Mullen EA; Chi YY; Ehrlich PF; Perlman EJ; Kalapurakal JA; Khanna G; Paulino AC; Hamilton TE; Gow KW; Tochner Z; Hoffer FA; Withycombe JS; Shamberger RC; Kim Y; Geller JI; Anderson JR; Grundy PE; Dome JS
    J Clin Oncol; 2018 Jan; 36(3):254-261. PubMed ID: 29211618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of Wilms tumor treatment in western Kenya.
    Uittenboogaard A; Njuguna F; Mostert S; Langat S; van de Velde ME; Olbara G; Vik TA; Kaspers GJL
    Pediatr Blood Cancer; 2022 Apr; 69(4):e29503. PubMed ID: 34908225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.